Several signaling pathways were also observed that allow for further studies, such as the HIF-1 signaling pathway, EGFR tyrosine kinase inhibitor resistance (Cancer), ERK and HER signaling (cancer), and PI3K signaling (cancer) which have the potential to be continued with molecular docking as a receptor. The gene discussed is EGFR; the disease is cancer.